Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H18N6O.2ClH |
Molecular Weight | 371.265 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.O=C(CNCCNC1=NC=C(C=C1)C#N)N2CCC[C@H]2C#N
InChI
InChIKey=VNACOBVZDCLAEV-GXKRWWSZSA-N
InChI=1S/C15H18N6O.2ClH/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17;;/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20);2*1H/t13-;;/m0../s1
Molecular Formula | C15H18N6O |
Molecular Weight | 298.343 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL284 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10512614 |
11.0 nM [Ki] | ||
Target ID: CHEMBL284 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10512614 |
11.0 nM [Ki] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:07:02 GMT 2023
by
admin
on
Fri Dec 15 16:07:02 GMT 2023
|
Record UNII |
PWKTKAMJUR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9799555
Created by
admin on Fri Dec 15 16:07:02 GMT 2023 , Edited by admin on Fri Dec 15 16:07:02 GMT 2023
|
PRIMARY | |||
|
PWKTKAMJUR
Created by
admin on Fri Dec 15 16:07:02 GMT 2023 , Edited by admin on Fri Dec 15 16:07:02 GMT 2023
|
PRIMARY | |||
|
207556-62-5
Created by
admin on Fri Dec 15 16:07:02 GMT 2023 , Edited by admin on Fri Dec 15 16:07:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Potent, orally active dipeptidyl peptidase (DPP)-IV inhibitor (Ki = 11 nM, IC50 = 14 nM) that displays > 15 000-fold selectivity over DPP-II and a range of proline-cleaving proteases. Exhibits antidiabetic activity in vivo improves glucose tolerance, increases glucagon-like peptide 1 (GLP-1) and insulin levels, augments insulin secretion and GLUT2 levels, and reduces (preserves) islet size.
|